Preclinical safety evaluation of dilevalol (SCH 19927), an antihypertensive agent, in the rat.
Selan F, McCullough CB, Black HE.
Fundam Appl Toxicol · journal article · DOI 10.1016/0272-0590(92)90145-8 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för dilevalol hydrochloride. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
13 träffarRole of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
Watkins RW, Sybertz EJ, Cook J, Pula K, Cedeno K, Tedesco RP, McLeod R.
Arch Int Pharmacodyn Ther · journal articleHigh-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
Alton KB, Petruzzi RF, Patrick JE.
J Chromatogr · journal article · DOI 10.1016/0378-4347(88)80040-9Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
Wallin JD, Cook ME, Clifton GG, Blasucci DJ, Poland M.
Arch Intern Med · journal article · DOI 10.1001/archinte.148.3.534Cardiac electrophysiologic actions of SCH 19927 (Dilevalol), the R,R-isomer of labetalol.
Lynch JJ, Montgomery DG, Lucchesi BR.
J Pharmacol Exp Ther · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(25)23368-7Comparison of the effects of labetalol and SCH 19927, the R1R isomer of labetalol, on the rat isolated right ventricle and aorta.
Doggrell SA, Hughes EW.
J Auton Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1474-8673.1985.tb00551.xComparative effects of SCH 19927 and timolol on intraocular pressure of conscious rabbits and relative systemic beta-blockade resulting from topical administration.
Watkins RW, Cummins DP, Vander Vliet G, Glennon J, Baum T.
J Ocul Pharmacol · comparative study; journal article · DOI 10.1089/jop.1985.1.161Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
Monopoli A, Bamonte F, Forlani A, Ongini E, Parravicini L.
Arch Int Pharmacodyn Ther · comparative study; journal articleTapetal changes in beagle dogs. I. Ocular changes after oral administration of a beta-adrenergic blocking agent--SCH 19927.
Schiavo DM, Sinha DP, Black HE, Arthaud L, Massa T, Murphy BF, Szot RJ, Schwartz E.
Toxicol Appl Pharmacol · journal article · DOI 10.1016/0041-008x(84)90302-8Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
Baum T, Sybertz EJ.
Fed Proc · journal articleSynthesis and comparison of some cardiovascular properties of the stereoisomers of labetalol.
Gold EH, Chang W, Cohen M, Baum T, Ehrreich S, Johnson G, Prioli N, Sybertz EJ.
J Med Chem · journal article · DOI 10.1021/jm00353a017Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
Sybertz EJ, Sabin CS, Pula KK, Vliet GV, Glennon J, Gold EH, Baum T.
J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(25)32689-3Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
Baum T, Watkins RW, Sybertz EJ, Vemulapalli S, Pula KK, Eynon E, Nelson S, Vliet GV, Glennon J, Moran RM.
J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(25)32690-x